RHYTHM PHARMACEUTICALS INC (RYTM) Stock Balance Sheet
NASDAQ:RYTM - Nasdaq - US76243J1051 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 47.52M | 60.08M | 127.70M | 59.20M | 100.90M | |||
| Marketable Securities | 250.87M | 215.76M | 205.60M | 235.60M | 71.90M | |||
| Receivables | 19.31M | 14.87M | 6.20M | 1.00M | N/A | |||
| Inventories | 13.89M | 8.62M | 2.90M | N/A | N/A | |||
| Other Current Assets | 8.75M | 8.93M | 11.80M | 12.50M | 8.80M | |||
| Total Current Assets | 340.34M | 308.27M | 354.20M | 308.40M | 181.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.39M | 2.12M | 3.40M | 4.30M | 5.00M | |||
| Intangibles | 6.39M | 7.03M | 7.90M | 4.70M | N/A | |||
| Other Non-Current Assets | 12.45M | 15.33M | 17.00M | 12.10M | 400.00K | |||
| Total Non-Current Assets | 23.23M | 24.48M | 28.30M | 21.10M | 5.40M | |||
| TOTAL ASSETS | 363.57M | 332.75M | 382.50M | 329.50M | 187.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 39.50M | 39.56M | 33.60M | 30.70M | 13.10M | |||
| Accounts Payable | 4.89M | 4.88M | 4.80M | 5.70M | 4.90M | |||
| Other Current Liabilities | 53.22M | 10.76M | 1.40M | 7.00M | N/A | |||
| Total Current Liabilities | 97.61M | 55.20M | 39.80M | 43.40M | 18.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 109.24M | 106.14M | 75.80M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 4.03M | 1.64M | 2.60M | 1.90M | 2.60M | |||
| Total Non-Current Liabilities | 113.27M | 107.78M | 78.40M | 2.00M | 2.50M | |||
| TOTAL LIABILITIES | 210.88M | 162.99M | 118.20M | 45.40M | 20.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.11B | -894.74M | -710.10M | -528.90M | -459.30M | |||
| Additional Paid In Capital | 1.12B | 1.06B | 974.40M | 813.00M | 625.80M | |||
| Common Shares | 141.54M | 59.00K | 100.00K | 100.00K | 0.00 | |||
| Other Shareholders' Equity | -604.00K | 134.00K | -100.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 61.44M | 59.43M | 56.60M | 50.30M | 44.20M | |||
| Tangible Book Value per Share | 0.08 | 2.74 | 4.53 | 5.56 | 3.77 | |||
| Total Shareholders' Equity | 152.70M | 169.76M | 264.30M | 284.20M | 166.50M | |||
| TOTAL LIABILITIES AND EQUITY | 363.57M | 332.75M | 382.50M | 329.50M | 187.10M | |||
| Statistics | ||||||||
| Debt/Equity | 0.72 | 0.63 | 0.29 | N/A | N/A | |||
| Current Ratio | 3.49 | 5.58 | 8.90 | 7.11 | 10.09 | |||
| Return On Assets (ROA) | -110.83% | -55.50% | -47.35% | -21.13% | -71.62% | |||
| Return On Equity (ROE) | -263.89% | -108.79% | -68.53% | -24.49% | -80.48% | |||
All data in USD , ROIC based on taxRate of 0.21